ALGS vs SO · rev $3.6M vs P/E 22, rev $6.26B
Aligos Therapeutics Inc (ALGS) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
ALGS currently screens at market cap $44.1M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the ALGS and SO stock pages for the full models.
Not investment advice.